Poster printing

Pfizer Inc. has agreed to buy closely held FoldRx Pharmaceuticals Inc. as it looks to expand into medicines for rare disorders. FoldRx, of Cambridge, is focused on developing treatments for conditions caused by the improper folding of proteins. Pfizer – Cambridge – Pharmaceutical drug – Pharmaceutical industry – Cambridge Massachusetts